Tritonix.ai

News / Taiwan / economic_daily

Chang Gung Medical Targets Double-Digit Growth by 2027 on Overseas Expansion

Health Technology · Medical Specialties · economic_daily · 2026-11-16

6730

Minimally invasive surgical instrument maker Chang Gung Medical expects double-digit growth by 2027, driven by new client acquisitions in Japan and Southeast Asia.

What Happened

Growth Drivers: Chairman Chen Cheng-hung stated that with the introduction of new clients in overseas markets and increased automated production capacity, the company expects revenue growth in 2027 to outperform this year, targeting double-digit growth.

Financial Results: The company reported a net profit of NT$52.13 million for the first three quarters, with an EPS of NT$1.44. Cumulative revenue for the first ten months reached NT$416 million, a 2.38% year-on-year increase.

Market Strategy: Asia accounts for 75% of revenue, with Europe contributing 20%. The Japanese market is expected to be a key growth engine next year as the company's electrosurgical products gain traction with existing clients.

Development Roadmap: Given the long certification cycles in the medical device industry, Chang Gung's multi-year investment in regulatory compliance and client development is now entering a harvest phase, with client numbers expected to grow at a double-digit rate.

Read original

More in Health Technology

Latest in Taiwan